- Home
- FBRX vs EVGN Comparison
FBRX vs EVGN Comparison
Compare FBRX & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- EVGN
- Stock Information
- Founded
- FBRX N/A
- EVGN 1999
- Country
- FBRX United States
- EVGN Israel
- Employees
- FBRX N/A
- EVGN N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- FBRX Health Care
- EVGN Industrials
- Exchange
- FBRX Nasdaq
- EVGN Nasdaq
- Market Cap
- FBRX 8.3M
- EVGN 9.7M
- IPO Year
- FBRX N/A
- EVGN N/A
- Fundamental
- Price
- FBRX $19.34
- EVGN $1.35
- Analyst Decision
- FBRX Strong Buy
- EVGN Strong Buy
- Analyst Count
- FBRX 3
- EVGN 1
- Target Price
- FBRX $77.58
- EVGN $12.00
- AVG Volume (30 Days)
- FBRX 140.5K
- EVGN 58.6K
- Earning Date
- FBRX 11-14-2024
- EVGN 11-21-2024
- Dividend Yield
- FBRX N/A
- EVGN N/A
- EPS Growth
- FBRX N/A
- EVGN N/A
- EPS
- FBRX N/A
- EVGN N/A
- Revenue
- FBRX N/A
- EVGN $7,478,000.00
- Revenue This Year
- FBRX N/A
- EVGN $90.35
- Revenue Next Year
- FBRX N/A
- EVGN $38.71
- P/E Ratio
- FBRX N/A
- EVGN N/A
- Revenue Growth
- FBRX N/A
- EVGN 30.69
- 52 Week Low
- FBRX $4.11
- EVGN $1.20
- 52 Week High
- FBRX $28.68
- EVGN $10.40
- Technical
- Relative Strength Index (RSI)
- FBRX 54.31
- EVGN 36.47
- Support Level
- FBRX $17.50
- EVGN $1.20
- Resistance Level
- FBRX $20.97
- EVGN $1.49
- Average True Range (ATR)
- FBRX 2.93
- EVGN 0.12
- MACD
- FBRX -1.12
- EVGN 0.01
- Stochastic Oscillator
- FBRX 16.46
- EVGN 35.71
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.